These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 36206062)
21. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database. Bae JP; Duan R; Fu H; Hoogwerf BJ Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218 [TBL] [Abstract][Full Text] [Related]
22. Hypoglycemic events and glycemic control effects between NPH and premixed insulin in patients with type 2 diabetes mellitus: A real-world experience at a comprehensive specialized hospital in Ethiopia. Sendekie AK; Netere AK; Belachew EA PLoS One; 2022; 17(9):e0275032. PubMed ID: 36149907 [TBL] [Abstract][Full Text] [Related]
23. The Rate of Insulin use and Suboptimal Glycemic Control among Egyptian Patients with T2DM: Cohort Analysis of Eighth Wave of the International Diabetes Management Practices Study (IDMPS). Khalil SHA; Khaled M; Zakhary R; Shereen M Curr Diabetes Rev; 2024; 20(3):e020623217590. PubMed ID: 37264625 [TBL] [Abstract][Full Text] [Related]
24. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Kinsley B Clin Ther; 2007; 29 Suppl D():S153-60. PubMed ID: 18191067 [TBL] [Abstract][Full Text] [Related]
25. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. DeWitt DE; Hirsch IB JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137 [TBL] [Abstract][Full Text] [Related]
26. Determinants of glycemic control among insulin treated diabetic patients in Southwest Ethiopia: hospital based cross sectional study. Angamo MT; Melese BH; Ayen WY PLoS One; 2013; 8(4):e61759. PubMed ID: 23620789 [TBL] [Abstract][Full Text] [Related]
27. [Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen]. Bu S; Guo XH; Yang WY; Lu GZ; Yang ZJ; Ren TT; Gao Y Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3115-8. PubMed ID: 18269868 [TBL] [Abstract][Full Text] [Related]
28. Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Giugliano D; Chiodini P; Maiorino MI; Bellastella G; Esposito K Endocrine; 2016 Mar; 51(3):417-28. PubMed ID: 26281001 [TBL] [Abstract][Full Text] [Related]
29. Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program. Philis-Tsimikas A; Zhang Q; Walker C Am J Ther; 2006; 13(6):466-72. PubMed ID: 17122525 [TBL] [Abstract][Full Text] [Related]
30. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation. Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Analogue insulin with other insulins in patients with type 1 diabetes in Ahmedabad, Western India: A Rretrospective study. Saiyed M; Saboo B; Pancholi M Diabetes Metab Syndr; 2020; 14(6):1923-1925. PubMed ID: 33032232 [TBL] [Abstract][Full Text] [Related]
32. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Vinik A Clin Ther; 2007 Jun; 29(6 Pt 1):1236-53. PubMed ID: 18036387 [TBL] [Abstract][Full Text] [Related]
33. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus. Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975 [TBL] [Abstract][Full Text] [Related]
34. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419 [TBL] [Abstract][Full Text] [Related]
35. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial. Heller S; Koenen C; Bode B Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879 [TBL] [Abstract][Full Text] [Related]
36. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus. Hemmingsen B; Metzendorf MI; Richter B Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147 [TBL] [Abstract][Full Text] [Related]
37. Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes. Qayyum R; Bolen S; Maruthur N; Feldman L; Wilson LM; Marinopoulos SS; Ranasinghe P; Amer M; Bass EB Ann Intern Med; 2008 Oct; 149(8):549-59. PubMed ID: 18794553 [TBL] [Abstract][Full Text] [Related]
38. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002. Fox KM; Gerber Pharmd RA; Bolinder B; Chen J; Kumar S Clin Ther; 2006 Mar; 28(3):388-95. PubMed ID: 16750453 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V). Liu J; Jiang X; Xu B; Wang G; Cui N; Zhang X; Liu J; Mu Y; Guo L Adv Ther; 2020 Apr; 37(4):1675-1687. PubMed ID: 32130661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]